NIH grant explores repetitive DNA sequences

Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.

Pandemic linked to 14% increase in underweight children in India

Malnutrition of Indian children rose dramatically during the COVID-19 pandemic, according to new research from the Tata-Cornell Institute for Agriculture and Nutrition.

ILR trio secures grant to study health care unions in the South

A new grant awarded by the Robert Woods Johnson Foundation will fund an interdisciplinary team featuring MIT and Tougaloo College scholars.

Around Cornell

Bacterial test for raw, organic milk may require more precision

Cornell food scientists show that a standard quality test used for raw, organic milk is insufficient for distinguishing between specific groups of bacteria -- suggesting that criteria needs updating.

Light, labor inducer could treat skin condition

Patients with vitiligo may have relief thanks to an unlikely cocktail of a molecule that induces labor, an immunosuppressant medication and controlled UVB irradiation.

French bulldog puppy spontaneously regrows jaw

A puppy’s jaw spontaneously regrew after Cornell veterinarians removed a majority of his lower left mandible due to cancer – the first reported case of its kind for dogs of any age or breed.

AI, Python, and R training starts Feb. 6

Cornell’s Scientific Computing Training Series resumes Feb. 6.

Around Cornell

Gene expression atlas captures where ovulation can go awry

An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice, an approach that could lead to therapeutic treatments for infertility.

Structural study points the way to better malaria drugs

Structural insights into a potent antimalarial drug candidate’s interaction with a malaria parasite have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.